Vertos Medical offers interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.
The integration brings offerings for joint replacement, spine, trauma, sports medicine, robotics and more.
This technology has been shown to grow bone rapidly in vivo without inducing bone synthesis at ectopic sites by non-bone cells.
The company seeks to sell its Poly-gamma-glutamic Acid technology related to OA, plus various intellectual property and know-how assets.
The acquired business will operate as an independent entity and has been renamed Highridge Medical.
The acquisition will leverage Innosys’ R&D in the spine segment, synergizing with CG Bio’s orthobiologic and spinal devices.
Zeda will produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible trauma implants to patients on a worldwide scale.
CartiHeal is the developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.
Enovis’ $844 million acquisition of LimaCorporate is expected to elevate the company’s recon segment to $1 billion in annual sales.
The company will acquire a majority interest in TriMed and enter a strategic relationship with Extremity Medical.
The transaction will allow ZimVie to streamline operations and sharpen its focus as a well-positioned, pure-play dental company in higher-growth end markets.
SERF is recognized worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup.
Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now.
Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices.
TeDan produces surgical access systems with a specialty focus in spine, neuro, orthopedic and cardiothoracic surgery.
Agili-C is a novel sports medicine technology developed to treat cartilage regeneration in the knee.
Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business and assumed the lease for the nanOss production facility.
As a guest member you get access to more articles and videos every month.
We’ll send a recovery link to your email.
Return to Homepage